Viewing Study NCT04045158


Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2025-12-25 @ 10:29 PM
Study NCT ID: NCT04045158
Status: UNKNOWN
Last Update Posted: 2019-08-05
First Post: 2019-07-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Diaphragm Ultrasound in Neuromuscular Disorders
Sponsor: Centre d'Investigation Clinique et Technologique 805
Organization:

Study Overview

Official Title: Diaphragm Ultrasound in Neuromuscular Disorders
Status: UNKNOWN
Status Verified Date: 2019-08
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Muscular dystrophies are neurologic disease with higher morbidity and mortality. Cardiac function and respiratory muscles can be affected, in addition with skeletal muscle deficiency . Lung function is classically assessed with functionnal pulmonary tests (FPT) . Ultrasound recently emerged as a non-invasive tool to assess diaphragm function.

The aims of the study are:

* to provide the spectrum of diaphragm ultrasound in patients with muscular dystrophies
* to assess the correlation between diaphragm ultrasound and FPT
* to assess the correlation between diaphragm ultrasound and cardiac function
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: